Jeuveau FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved February 1, 2019)
Brand name: Jeuveau
Generic name: prabotulinumtoxinA-xvfs
Dosage form: Injection
Company: Evolus, Inc.
Treatment for: Glabellar Lines
Jeuveau (prabotulinumtoxinA) is a proprietary 900 kDa purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar (frown) lines.
Development timeline for Jeuveau
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
